2025 Annual Meeting of Stockholders
Latest Presentations
Upcoming Event
Latest News
Sign Up For Email Alerts
Receive updates straight into your inbox
Company Overview
ProPhase Labs Inc. (Nasdaq: PRPH) (“ProPhase”) is a next-generation biotech, genomics and consumer products company. Our goal is to create a healthier world with bold action and the power of insight. We’re revolutionizing healthcare with industry-leading Whole Genome Sequencing solutions, while developing potential game changer diagnostics and therapeutics in the fight against cancer. This includes a potentially life-saving cancer test focused on early detection of esophageal cancer and potential breakthrough cancer therapeutics with novel mechanisms of action. We develop, manufacture, and commercialize health and wellness solutions to enable people to live their best lives. We are committed to executional excellence, smart diversification, and a synergistic, omni-channel approach. ProPhase Labs’ valuable subsidiaries, their synergies, and significant growth underscore our potential for long-term value.
Investor Contact Information
Company
ProPhase Labs, Inc.
711 Stewart Ave
Suite 200
Garden City, NY 11530
Investor Relations
Institutional Investor Relations
T: 267-880-1111
investorrelations@prophaselabs.com
Retail Investor Relations
John Boidman
Renmark Financial Communications
T: 514-939-3989
jboidman@renmarkfinancial.com